WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 5801 Infant (under 12 months) mortality rate: 532
GDP / capita (US$): 1'1861 Child (under 5 years) mortality rate: 712

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 29'669  28'829  28'011  27'212  26'434  18'068  13'248  11'848 
Births 1'146  1'125  1'105  1'085  1'065  818  625  557 
Surviving infants 1'073  1'052  1'032  1'013  993  733  536  474 
Pop. less than 5 years 5'047  4'950  4'844  4'743  4'644  3'290  2'392  2'139 
Pop. less than 15 years 13'289  12'979  12'661  12'353  12'039  8'129  6'254  5'239 
Female 15-49 years 6'988  6'767  6'559  6'354  6'160  4'339  3'024  2'769 

Number of reported cases

(Click for retrospective incidence data for Mozambique)
Diphtheria
ChartChart
  11 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  122  79  7'375  18'082  30'070 
Mumps
ChartChart
 
Pertussis
ChartChart
  94  451 
Polio*
ChartChart
  65 
Rubella
ChartChart
  102  210  127 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  271  59  42  34  101 
Tetanus (total)**
ChartChart
  281  59  65  102  573 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mozambique)
Vaccine year result method % card seen                                                
BCG 2010  91  DHS   83  99  99*  95  94  93  99*  59 
DTP1 2010  91  DHS   83  99  99*  90  93  93  99* 
DTP3 2010  76  DHS   83  99  96  80  88  78  88  46 
DTP4         
IPV1          73  84  93 
HepB_BD         
HepB3          99  96  80  88  78 
Hib3          99  96  80  88  78 
JapEnc         
MCV1          99  91  85  87  85  97  59 
MCV2          60  51 
MenA         
PCV1          99  99*  90  91  80 
PCV2          99  95  85  89  70 
PCV3          99  95  80  88  60 
Pol3 2010  73  DHS   83  99  91  80  88  78  87  46 
Rota1          99  88  99* 
RotaC          94  76  59 
RCV1         
TT2plus 2010  56  DHS   83  86  92  80  66  64  61  21 
PAB         
VAD1          80  66 
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mozambique)
BCG
ChartChart
  95  95  94  93  84  59 
DTP1
ChartChart
  90  90  92  93  84  71 
DTP3
ChartChart
  80  80  79  78  70  46 
HepB3
ChartChart
  80  80  79  78 
HepB_BD
 
Hib3
ChartChart
  80  80  79  78 
IPV1
 
MCV1
ChartChart
  85  85  85  85  71  59 
MCV2
ChartChart
 
PCV3
ChartChart
  80  80  73  45 
Pol3
ChartChart
  80  80  79  78  69  46 
RCV1
 
RotaC
ChartChart
  17  17 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 161  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 82
From 80 to 89% 9
From 50 to 79% 7
Less than 50% 1
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepB 6, 10, 14 weeks; Yes
HepA_Adult 18+ years; Yes 18-65 years
HPV 1st contact; +4 weeks; 0 9-13 year old females only
IPV 14 weeks; Yes
Measles 9, 18 months; Yes
MR 9, 18 months; from April 2018
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 18 weeks; Yes
Rotavirus 6, 10 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes school age 15-49 years
VitaminA 6, 12, 18, 24, 30, 36 months;

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2014-2019    2015-2019  2014-2018  2014-2018  2012-2016  2012-2016 
Nº of districts with microplans that include activities to raise immunization coverage number 20    148  148  148  148  144 

System performance

Total Nº districts in country number 161  159  148  148  148  148  144 
Nº districts with DTP3 coverage >=80% number 146    127  130  128  136  98 
% of districts with DTP3 coverage >=80% From 0 to 100% 91    86  88  86  92  68 
Nº districts with measles (MCV1) coverage >=95% number 113    55  67  44  63  42 
% of districts with MCV1 coverage >=95% From 0 to 100% 70    37  45  30  43  29 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No    No  Yes  No  No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    No  Yes  No  No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     20    23  34  24 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.